Acyclovir prophylaxis for oral herpes simplex virus infection in patients with bone marrow transplants

Spencer W. Redding, Michael T. Montgomery

Research output: Contribution to journalArticle

29 Scopus citations

Abstract

Reactivation of herpes simplex virus (HSV) appears to play a significant role in oral mucositis resulting from bone marrow transplantation. The acyclic guanosine derivative acyclovir has been shown to be effective in treating and protecting against HSV infection in this group. The purpose of this study was to determine the role of HSV reactivation in oral mucositis in patients undergoing bone marrow transplantation who were seronegative for HSV or who received acyclovir prophylaxis. The results suggest that HSV plays an insignificant role in oral mucositis in these patients.

Original languageEnglish (US)
Pages (from-to)680-683
Number of pages4
JournalOral Surgery, Oral Medicine, Oral Pathology
Volume67
Issue number6
DOIs
StatePublished - Jun 1989

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Dentistry(all)

Fingerprint Dive into the research topics of 'Acyclovir prophylaxis for oral herpes simplex virus infection in patients with bone marrow transplants'. Together they form a unique fingerprint.

Cite this